| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
XMD17-109
|
1435488-37-1 |
11-环戊基-2-[[2-乙氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二氢-5-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮
|
11-环戊基-2-[[2-乙氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二氢-5-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮;XMD17 109;XMD17109;CS-1288
|
C36H46N8O3 |
638.80224 | |
|
WH-4-023
|
837422-57-8 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE
|
2,6-二甲基苯基 N-[2,4-二(甲氧基)苯基][2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基甲酸酯;DUAL LCK/SRC INHIBITOR;KIN001-112; KIN112
|
C32H36N6O4 |
568.68 | |
|
NG-25
|
1315355-93-1 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺
|
HG-7-92-01
(NG 25);3-((1H-Pyrrolo[2,3-b]pyridin-4-yl)oxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide;NG25;NG-25;N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide;3-((1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3v-(trifluoromethyl)phenyl)-4-methylbenzamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide
|
|||
|
L 2-401
|
883050-24-6 |
4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮
|
CS-563;CCG50014;CCG 50014;4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮
|
C16H13FN2O2S |
316.350023 | |
|
CZC24832
|
1159824-67-5 |
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺
|
CS-957;5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺;CZC 24832;CZC-24832
|
C15H17FN6O2S |
364.3978832 | 200-258-5 |
|
N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
|
170449-18-0 |
N-(3-氯苯基)-6,7-二甲氧基-4-喹唑啉胺盐酸盐
|
N-(3-氯苯基)-6,7-二甲氧基-4-喹唑啉胺盐酸盐
|
C16H14ClN3O2.HCl |
352.2152 | |
|
1400W Di hydrochloride
|
214358-33-5 |
N-[3-(氨甲基)苄基]乙脒二盐酸盐
|
N-[[3-(氨基甲基)苯基]甲基]乙脒二盐酸盐;N-([3-(AMINOMETHYL)PHENYL]METHYL)ETHANIMIDAMIDE 二盐酸盐;N-[3-(氨甲基)苄基]乙脒二盐酸盐
|
C8H11NO |
137.17904 | |
|
2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl(phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
|
1234480-50-2 |
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮
|
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮;CS-641
|
C26H30N6O3 |
475 | |
|
(E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE
|
1395084-25-9 |
(E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE
|
|
C18H17N5O3S |
383.42428 | |
|
Butabindide oxalate
|
185213-03-0 |
[S-(R*,R*)]-1-(2-氨基-1-氧代丁基)-N-丁基-2,3-二氢-1H-吲哚-2-甲酰胺草酸盐
|
[S-(R*,R*(]-1-(2-氨基-1-氧代丁基)-N-丁基-2,3-二氢-1H-吲哚-2-甲酰胺草酸盐
|
C19H27N3O6 |
393.43418 | |
|
AR-C155858
|
496791-37-8 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮
|
AR-C155858;AR C155858;(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮;AR-C 155858;AR C15585
|
C21H26N5O5S |
460.52664 | |
|
PF-03814735
|
942487-16-3 |
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺
|
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺;CS-240
|
C23H25F3N6O2 |
474.4788096 | -0 |
|
SB-674042
|
483313-22-0 |
(S)-1-[5-[2-氟苯基]-2-甲基噻唑-4-基]-1-[2-[[5-苯基-[1,3,4]恶二唑-2-基]甲基]吡咯烷-1-基]甲酮
|
(S)-1-[5-[2-氟苯基]-2-甲基噻唑-4-基]-1-[2-[[5-苯基-[1,3,4]恶二唑-2-基]甲基]吡咯烷-1-基]甲酮;[5-(2-FLUOROPHENYL)-2-METHYL-1,3-THIAZOL-4-YL]-[(2S)-2-[(5-PHENYL-1,4-OXADIAZOL-2-YL)METHYL]PYRROLIDIN-1-YL]METHANONE;SB 674042;SB674042
|
C24H21FN4O2S |
448.512543 | |
|
5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT
|
1047953-91-2 |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺
|
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺;5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT;TELOMERASE INHIBITOR II, SODIUM SALT;MI-2;MI 2 (MALT1 inhibitor);2-Chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl]phenyl]-Acetamide;ATP-dependent helicase CHD4;CHD-4
|
|||
|
GSK J4 Hydrochloride
|
1373423-53-0 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
|
CS-1667;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯;GSK J4 游离(检测J4溶样不要用甲醇,会发生酯交换);CS-2143;GSK J4 游离(检测J4溶样不要用甲醇,会发生酯交换)
|
C24H27N5O2 |
417.50348 | |
|
SNS-314
|
1146618-41-8 |
N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐 (1:1)
|
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea methanesulfonate (1:1);SNS-314 Mesylate;M1-(3-chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea Mesylate;N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea methanesulfonate (1:1) SNS-314 Mesylate;SNS-314 mesylate, >=98%;1-(3-chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea methanesulfonate;N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea methanesulfonate
|
C19H19ClN6O4S3 |
527.03996 | |
|
CORM-3
|
475473-26-8 |
(OC-6-44)-三羰基氯(甘氨酸基)钌
|
Tricarbonylchloro(glycinato)ruthenium;(OC-6-44)-Tricarbonylchloro(glycinato)ruthenium;Ruthenium, tricarbonylchloro(glycinato-κN,κO)-, (OC-6-44)-;Carbon monoxide releasing molecule 3;Tricarbonylchloro(glycinato)ruthenium (II)
|
|||
|
chlorphentermine hydrochloride
|
151-06-4 |
4-氯-ALPHA,ALPHA-二甲基苯乙胺盐酸盐
|
4-氯-ALPHA,ALPHA-二甲基苯乙胺盐酸盐;[2-(4-氯苯基)-1,1-二甲基乙基]胺盐酸盐
|
C10H14ClN.ClH |
220.1388 | 205-782-9 |
|
kb NB 142-70
|
1233533-04-4 |
3,4-二氢-9-羟基-[1]苯并噻吩并[2,3-F]-1,4-硫氮杂卓-5(2H)-酮
|
3,4-二氢-9-羟基-[1]苯并噻吩并[2,3-F]-1,4-硫氮杂卓-5(2H)-酮>98%;3,4-硫氮杂卓-5(2H)-酮;CS-2453
|
C11H9NO2S2 |
251.32466 | |
|
Venlafaxine hydrochloride
|
99300-78-4 |
盐酸文拉法辛
|
文拉法辛盐酸盐;盐酸维拉法辛;维拉法辛;文法拉辛;盐酸文拉法辛,一种5-羟色胺-去甲肾上腺素再摄取抑制剂;VENLAFAXINE 盐酸盐;盐酸文法拉辛;盐酸文拉法辛 101G
|
C17H27NO2·HCl;C17H28ClNO2 |
313.87 | 619-421-1 |
药智官方微信
药智官方微博
